Structures by: Palma A.
Total: 129
C64H44CoN6
C64H44CoN6
Dalton Transactions (2009) 2 273-279
a=19.860(3)Å b=44.375(5)Å c=10.7534(13)Å
α=90.00° β=90.00° γ=90.00°
C64H44CuN6
C64H44CuN6
Dalton Transactions (2009) 2 273-279
a=19.8465(18)Å b=44.707(4)Å c=10.6333(10)Å
α=90.00° β=90.00° γ=90.00°
C64H44N6Zn
C64H44N6Zn
Dalton Transactions (2009) 2 273-279
a=19.884(2)Å b=44.428(4)Å c=10.7669(11)Å
α=90.00° β=90.00° γ=90.00°
C64H44N6Ni
C64H44N6Ni
Dalton Transactions (2009) 2 273-279
a=19.842(3)Å b=44.333(5)Å c=10.7588(14)Å
α=90.00° β=90.00° γ=90.00°
(E)-3-benzoyl-2-methyl-4-(3-methylstyryl)quinoline
C26H21NO
Acta Crystallographica Section C (2020) 76, 9
a=13.2730(16)Å b=14.8012(16)Å c=20.137(2)Å
α=90° β=90° γ=90°
(E)-1-(2-Methyl-4-((E)-4-methylstyryl)quinolin-3-yl)-3- phenyl-prop-2-en-1-one
C28H23NO
Acta Crystallographica Section C (2020) 76, 9
a=10.8168(6)Å b=17.3361(10)Å c=12.8892(6)Å
α=90° β=114.132(2)° γ=90°
(<i>E</i>)-3-Acetyl-2-methyl-4-(4-methoxystyryl)quinoline
C21H19NO2
Acta Crystallographica Section C (2020) 76, 9
a=8.2595(4)Å b=6.4279(3)Å c=31.9064(14)Å
α=90° β=93.674(2)° γ=90°
(<i>E</i>)-3-Acetyl-4-(4-bromostyryl)-2-methylquinoline
C20H16BrNO
Acta Crystallographica Section C (2020) 76, 9
a=8.0849(3)Å b=6.6692(2)Å c=31.1063(10)Å
α=90° β=95.0050(10)° γ=90°
Ethyl (<i>E</i>)-4-(4-bromostyryl)-2-methylquinoline-3-carboxylate
C21H18BrNO2
Acta Crystallographica Section C (2020) 76, 9
a=9.5709(6)Å b=10.6119(7)Å c=18.2074(10)Å
α=90° β=90.939(2)° γ=90°
Ethyl (<i>E</i>)-2-methyl-4-(4-methoxystyryl)quinoline-3-carboxylate
C22H21NO3
Acta Crystallographica Section C (2020) 76, 9
a=9.5301(8)Å b=10.3513(8)Å c=10.3621(8)Å
α=65.374(3)° β=86.583(3)° γ=76.376(3)°
Ethyl (<i>E</i>)-2-methyl-4-[4-(trifluoromethyl)styryl]quinoline-3-carboxylate
C22H18F3NO2
Acta Crystallographica Section C (2020) 76, 9
a=8.7465(10)Å b=9.9436(11)Å c=11.1116(11)Å
α=105.446(4)° β=99.763(4)° γ=97.204(4)°
Ethyl 2-chloro-13-ethyl-4-oxo-8,13-dihydro-4<i>H</i>-benzo[5,6]azepino[3,2,1-<i>ij</i>]quinoline-5-carboxylate
C22H20ClNO3
Acta Crystallographica Section C (2017) 73, 1 28-35
a=6.8533(16)Å b=10.612(5)Å c=13.561(3)Å
α=72.45(4)° β=75.840(19)° γ=82.46(2)°
(9<i>RS</i>,15<i>RS</i>)-9-Ethyl-7,12-dimethyl-9,13b-dihydrodibenzo[<i>c</i>,<i>f</i>]thiazolo[3,2-<i>a</i>]azepin-3(2<i>H</i>)-one
C20H21NOS
Acta Crystallographica Section C (2017) 73, 1 28-35
a=18.1021(12)Å b=12.4436(8)Å c=14.8429(9)Å
α=90° β=97.645(3)° γ=90°
(9<i>RS</i>,15<i>RS</i>)-9-Ethyl-11-methyl-9,13b-dihydrodibenzo[<i>c</i>,<i>f</i>]thiazolo[3,2-<i>a</i>]azepin-3(2<i>H</i>)-one
C19H19NOS
Acta Crystallographica Section C (2017) 73, 1 28-35
a=11.4261(5)Å b=8.1847(3)Å c=16.8243(6)Å
α=90° β=93.067(2)° γ=90°
Ethyl 13-ethyl-4-oxo-8,13-dihydro-4<i>H</i>-benzo[5,6]azepino[3,2,1-<i>ij</i>]quinoline-5-carboxylate heptane hemisolvate
C22H21NO3,0.5(C7H16)
Acta Crystallographica Section C Structural Chemistry (2018) 74, 12
a=11.9894(3)Å b=13.6171(4)Å c=14.3939(4)Å
α=89.4670(13)° β=74.3830(12)° γ=68.1250(12)°
Methyl (2<i>RS</i>,4<i>SR</i>)-7-chloro-4-(2-chloroacetoxy)-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepine-2-carboxylate
C14H15Cl2NO4
Acta Crystallographica Section C (2019) 75, 2
a=8.858(6)Å b=9.328(5)Å c=10.526(6)Å
α=96.039(18)° β=112.651(19)° γ=108.99(3)°
(4a<i>RS</i>,6<i>SR</i>)-9-Chloro-6-hydroxy-4a,5,6,7-tetrahydrobenzo[<i>f</i>][1,2,4]triazino[4,5-<i>a</i>]azepin-4(3<i>H</i>)-one
C12H12ClN3O2
Acta Crystallographica Section C (2019) 75, 2
a=5.595(4)Å b=8.377(5)Å c=12.712(8)Å
α=98.10(3)° β=100.10(2)° γ=101.76(3)°
(4a<i>RS</i>,6<i>SR</i>)-9-chloro-6-hydroxy-3-(2-hydroxyethyl)-2,3,4a,5,6,7-hexahydrobenzo[<i>f</i>]pyrazino[1,2-<i>a</i>]azepine-1,4-dione
C15H17ClN2O4
Acta Crystallographica Section C (2019) 75, 2
a=9.198(6)Å b=10.586(7)Å c=15.223(11)Å
α=90° β=105.56(2)° γ=90°
(3<i>RS</i>)-4-(2-Allyl-3,5-dimethylphenyl)-1-benzyl-3-phenylpiperazine-2,5-dione
C28H28N2O2
Acta Crystallographica Section C (2018) 74, 2
a=23.3641(8)Å b=10.0825(3)Å c=21.4524(7)Å
α=90° β=115.8850(10)° γ=90°
<i>N</i>,2,6,11-Tetramethyl-<i>N</i>-phenyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepin-4-amine
C22H24N4
Acta Crystallographica Section C (2018) 74, 3
a=11.2020(19)Å b=16.609(3)Å c=19.850(6)Å
α=90° β=90° γ=90°
5-Allyl-6-(1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-<i>N</i>-methyl-<i>N</i>-(4-methylphenyl)pyrimidin-4-amine
C22H21N5
Acta Crystallographica Section C (2018) 74, 3
a=9.425(2)Å b=11.184(3)Å c=17.321(6)Å
α=90° β=101.091(11)° γ=90°
6,7,9,11-Tetramethyl-4-(5-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C24H25N5
Acta Crystallographica Section C (2018) 74, 3
a=9.7866(13)Å b=10.2122(15)Å c=10.9551(14)Å
α=97.816(9)° β=112.433(8)° γ=94.149(8)°
(<i>RS</i>)-(<i>E</i>)-4-[2-(4-Chlorobenzylidene)hydrazinyl]-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C21H20ClN5
Acta Crystallographica Section C (2019) 75, 6
a=12.9010(15)Å b=20.055(3)Å c=8.7001(13)Å
α=90° β=123.161(7)° γ=90°
(<i>RS</i>)-(<i>E</i>)-4-[2-(4-Chlorobenzylidene)hydrazinyl]-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C21H20ClN5
Acta Crystallographica Section C (2019) 75, 6
a=8.8623(4)Å b=14.4656(7)Å c=14.2723(7)Å
α=90° β=90° γ=90°
Ethyl (<i>RS</i>)-13-ethyl-2-fluoro-4-oxo-8,13-dihydro-4<i>H</i>-benzo[5,6]azepino[3,2,1-<i>ij</i>]quinoline-5-carboxylate
C22H20FNO3
Acta Crystallographica Section C (2019) 75, 6
a=9.5920(6)Å b=13.4325(7)Å c=14.2186(8)Å
α=90° β=103.290(2)° γ=90°
(<i>RS</i>)-5-Acetyl-2-chloro-11-methyl-5,6,11,12-tetrahydrobenzo[<i>b</i>,<i>f</i>]azocine
C18H18ClNO
Acta Crystallographica Section C (2019) 75, 6
a=8.333(5)Å b=20.800(14)Å c=9.186(6)Å
α=90° β=107.857(17)° γ=90°
(6<i>RS</i>)-4-Chloro-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C14H14ClN3
Acta Crystallographica Section C (2015) 71, 12
a=8.6570(5)Å b=8.8622(17)Å c=9.0321(11)Å
α=92.649(13)° β=113.635(9)° γ=100.632(12)°
(6<i>RS</i>)-4-Chloro-8-methoxy-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C15H16ClN3O
Acta Crystallographica Section C (2015) 71, 12
a=8.2148(7)Å b=12.9078(8)Å c=15.0778(6)Å
α=90° β=122.774(5)° γ=90°
(6<i>RS</i>)-4-Chloro-8-hydroxy-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C14H14ClN3O
Acta Crystallographica Section C (2015) 71, 12
a=8.0251(7)Å b=21.5510(17)Å c=8.0709(6)Å
α=90° β=116.216(6)° γ=90°
(6<i>RS</i>)-4-Chloro-8-methoxy-6,11-dimethyl-2-phenyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C21H20ClN3O
Acta Crystallographica Section C (2015) 71, 12
a=13.9431(8)Å b=9.2078(10)Å c=14.802(4)Å
α=90° β=106.521(8)° γ=90°
(RS)-8-chloro-6-methyl-1,2,6,7-tetrahydropyrimido[5',4':6,7]azepino[3,2,1-hi]indole
C15H14ClN3
Acta Crystallographica Section C (2016) 72, 1 52-56
a=6.6250(3)Å b=22.4796(13)Å c=8.6355(4)Å
α=90° β=100.610(3)° γ=90°
(RS)-9-chloro-7-methyl-2,3,7,8-tetrahydro-1H-pyrimido[5',4':6,7]azepino[3,2,1-ij]-quinoline
C16H16ClN3
Acta Crystallographica Section C (2016) 72, 1 52-56
a=8.1840(10)Å b=9.5399(12)Å c=10.2185(19)Å
α=104.471(7)° β=101.049(6)° γ=111.324(5)°
(6<i>RS</i>,11<i>RS</i>)-11-Ethyl-6,11-dihydro-5<i>H</i>-dibenzo[<i>b</i>,<i>e</i>]azepine-6-carboxamide
C17H18N2O
Acta Crystallographica Section C (2016) 72, 7 549-554
a=5.6051(2)Å b=8.6411(3)Å c=14.3853(6)Å
α=86.192(2)° β=81.237(3)° γ=87.313(2)°
(2<i>RS</i>)-2,8-Dimethyl-4-phenyl-1,2-dihydro-6<i>H</i>-pyrrolo[3,2,1-<i>ij</i>]quinolin-6-one
C19H17NO
Acta Crystallographica Section C (2016) 72, 8
a=17.756(5)Å b=10.364(3)Å c=15.232(4)Å
α=90° β=92.774(8)° γ=90°
(2<i>SR</i>,4<i>RS</i>)-6,8-Dimethyl-2-(naphthalen-1-yl)-2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C22H21N1O1
Acta Crystallographica Section C (2016) 72, 5 363-372
a=24.8049(10)Å b=10.7126(5)Å c=12.1932(4)Å
α=90° β=95.9290(10)° γ=90°
7-Fluoro-<i>cis</i>-2-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro-1<i>H</i>-1-\ benzazepin-4-ol
C18H18FNO
Acta Crystallographica Section C (2016) 72, 5 363-372
a=7.5932(3)Å b=7.5859(4)Å c=51.010(3)Å
α=90° β=90° γ=90°
(2<i>SR</i>,4<i>RS</i>)-6,9-Dimethyl-2-(naphthalen-1-yl)-2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C22H21NO
Acta Crystallographica Section C (2016) 72, 5 363-372
a=7.5541(3)Å b=14.7914(5)Å c=15.4049(5)Å
α=90° β=90° γ=90°
7-Fluoro-<i>cis</i>-2-[(<i>E</i>)-pent-1-enyl]-2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepin-4-ol
C15H20FNO
Acta Crystallographica Section C (2016) 72, 5 363-372
a=25.119(2)Å b=25.119(2)Å c=11.2812(12)Å
α=90° β=90° γ=120°
7-Fluoro-<i>cis</i>-2-[(<i>E</i>)-pent-1-enyl]-2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepin-4-ol
C15H20FNO
Acta Crystallographica Section C (2016) 72, 5 363-372
a=49.395(2)Å b=49.395(2)Å c=11.1802(5)Å
α=90° β=90° γ=120°
6,11-Dimethyl-3,5,6,11-tetrahydro-4<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepin-4-one
C14H15N3O
Acta Crystallographica Section C (2016) 72, 4 346-357
a=17.0839(16)Å b=4.2350(3)Å c=16.2258(18)Å
α=90° β=94.047(8)° γ=90°
4-Butoxy-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepin-8-ol
C18H23N3O2
Acta Crystallographica Section C (2016) 72, 4 346-357
a=11.4233(4)Å b=7.3707(3)Å c=20.4624(7)Å
α=90° β=93.561(2)° γ=90°
<i>N</i>-Benzyl-6-methyl-1,2,6,7-tetrahydropyrimido\ [5,4':6,7]azepino[3,2,1-<i>hi</i>]indol-8-amine
C22H22N4
Acta Crystallographica Section C (2016) 72, 4 346-357
a=7.7594(4)Å b=8.5383(6)Å c=13.4525(8)Å
α=90° β=100.483(3)° γ=90°
<i>N</i>-Benzyl-8-methoxy-6,11-dimethyl-6,11-dihydro-5<i>H</i>- benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepin-4-amine
C22H24N4O
Acta Crystallographica Section C (2016) 72, 4 346-357
a=12.2994(8)Å b=9.1501(5)Å c=16.1710(9)Å
α=90° β=95.289(2)° γ=90°
4-Dimethylamino-6,11-dimethyl-6,11-dihydro-5<i>H</i>-\ benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepin-8-ol
C16H20N4O
Acta Crystallographica Section C (2016) 72, 4 346-357
a=18.886(3)Å b=7.9898(15)Å c=19.335(3)Å
α=90° β=90° γ=90°
<i>N</i>-Benzyl-7-methyl-2,3,7,8-tetrahydro-1<i>H</i>-\ pyrimido[5,4':6,7]azepino[3,2,1-<i>ij</i>]quinolin-9-amine
C23H24N4
Acta Crystallographica Section C (2016) 72, 4 346-357
a=15.083(3)Å b=27.563(4)Å c=8.8681(13)Å
α=90° β=90° γ=90°
4,4'-(Phenylmethylene)bis(6-allyl-3-chloro-2-methylaniline)
C27H28Cl2N2
Acta Crystallographica Section C (2009) 65, 9 o479-o482
a=8.9868(2)Å b=10.8718(4)Å c=12.4359(4)Å
α=94.333(2)° β=93.634(3)° γ=102.490(2)°
(2<i>RS</i>,4<i>SR</i>)-2-<i>exo</i>-(5-bromo-2-thienyl)-7-chloro- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C14H11BrClNOS
Acta Crystallographica Section C (2009) 65, 9 o487-o491
a=10.7959(11)Å b=14.2116(16)Å c=17.4303(11)Å
α=90.00° β=90.00° γ=90.00°
4,4'-(2-thienylmethylene)bis(6-allyl-3-chloro-2-methylaniline)
C25H26Cl2N2S
Acta Crystallographica Section C (2009) 65, 9 o479-o482
a=8.7263(2)Å b=10.6766(2)Å c=12.2691(3)Å
α=77.1100(10)° β=87.7930(10)° γ=82.367(2)°
(2<i>RS</i>,4<i>SR</i>)-2-<i>exo</i>-(5-methyl-2-thienyl)-2,3,4,5- tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C15H15NOS
Acta Crystallographica Section C (2009) 65, 9 o487-o491
a=8.3789(12)Å b=9.6964(14)Å c=30.952(4)Å
α=90.00° β=90.00° γ=90.00°
(2<i>RS</i>,4<i>SR</i>)-7-chloro-2-<i>exo</i>-(5-methyl-2-thienyl)- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C15H14ClNOS
Acta Crystallographica Section C (2009) 65, 9 o487-o491
a=15.042(3)Å b=15.739(3)Å c=5.6216(13)Å
α=90.00° β=100.120(16)° γ=90.00°
(2<i>RS</i>,4<i>SR</i>)-7-Bromo-2-(2-methylphenyl)-2,3,4,5-tetrahydro-1<i>H</i>-naphtho[1,2-<i>b</i>]azepin-4-ol
C21H20BrNO
Acta Crystallographica Section C (2013) 69, 4 448-452
a=8.438(2)Å b=24.957(5)Å c=16.221(4)Å
α=90.00° β=93.914(16)° γ=90.00°
(2<i>RS</i>,4<i>SR</i>)-2-(3-Methylthiophen-2-yl)-2,3,4,5-tetrahydro-1<i>H</i>-naphtho[1,2-<i>b</i>]azepin-4-ol
C19H19NOS
Acta Crystallographica Section C (2013) 69, 4 448-452
a=25.431(5)Å b=16.318(3)Å c=8.0193(6)Å
α=90.00° β=104.021(10)° γ=90.00°
(2<i>R</i>*,4<i>S</i>*)-2-(Pyridin-3-yl)-2,3,4,5-tetrahydro-1<i>H</i>- 1-benzazepin-4-ol
C15H16N2O
Acta Crystallographica Section C (2011) 67, 5 o157-o160
a=6.0318(9)Å b=8.3396(10)Å c=25.361(4)Å
α=90.00° β=90.00° γ=90.00°
(2<i>R</i>*,4<i>S</i>*)-Methyl 4-hydroxy-2,3,4,5-tetrahydro-1<i>H</i>-benz[<i>b</i>]azepine-2-carboxylate
C12H15NO3
Acta Crystallographica Section C (2014) 70, 4 408-415
a=6.2528(13)Å b=10.758(3)Å c=15.927(5)Å
α=90.00° β=90.00° γ=90.00°
(2<i>R</i>*,4<i>S</i>*)-Methyl 2,3,4,5-tetrahydro-1,4-epoxy-1<i>H</i>-benz[<i>b</i>]azepine-2-carboxylate
C12H13NO3
Acta Crystallographica Section C (2014) 70, 4 408-415
a=6.8549(6)Å b=11.4483(12)Å c=13.1369(14)Å
α=90.00° β=90.00° γ=90.00°
(2<i>RS</i>,4<i>SR</i>)-4-Hydroxy-2,3,4,5-tetrahydro-1<i>H</i>-benz[<i>b</i>]azepine-2-carboxylic acid
C11H13NO3
Acta Crystallographica Section C (2014) 70, 4 408-415
a=9.4389(5)Å b=11.9081(5)Å c=9.2702(4)Å
α=90.00° β=108.275(3)° γ=90.00°
(6<i>R</i>*,11<i>R</i>*)-5-Acetyl-11-ethyl-6,11-dihydro-5<i>H</i>-dibenzo[<i>b</i>,<i>e</i>]azepine-6-carboxylic acid
C19H19NO3
Acta Crystallographica Section C (2014) 70, 3 332-337
a=8.8053(3)Å b=10.9821(4)Å c=9.0080(6)Å
α=90.00° β=118.510(3)° γ=90.00°
(6<i>RS</i>,11<i>SR</i>)-5-Acetyl-11-ethyl-2-methyl-6,11-dihydro-\ 5<i>H</i>-dibenzo[<i>b</i>,<i>e</i>]azepine-6-carboxylic acid
C20H21NO3
Acta Crystallographica Section C (2014) 70, 3 332-337
a=15.2894(16)Å b=10.760(2)Å c=10.538(2)Å
α=90.00° β=100.990(11)° γ=90.00°
(6<i>RS</i>,11<i>SR</i>)-5-Acetyl-11-ethyl-1,3-dimethyl-6,11-dihydro-\ 5<i>H</i>-dibenzo[<i>b</i>,<i>e</i>]azepine-6-carboxylic acid
C21H23NO3
Acta Crystallographica Section C (2014) 70, 3 332-337
a=9.2283(11)Å b=16.691(2)Å c=11.9824(18)Å
α=90.00° β=103.820(11)° γ=90.00°
7,9-dichloro-2-<i>exo</i>-(prop-1-en-2-yl)-2,3,4,5-tetrahydro- 1<i>H</i>-1,4-epoxy-1-benzazepine
C13H13Cl2NO
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=10.4753(13)Å b=5.4759(8)Å c=10.9632(12)Å
α=90.00° β=105.791(13)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-2-<i>exo</i>-vinyl-2,3,4,5-tetrahydro-1<i>H</i>- 1,4-epoxy-1-benzazepine
C12H13NO
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=9.8070(13)Å b=7.3982(7)Å c=13.738(2)Å
α=90.00° β=105.441(11)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-8-chloro-9-methyl-2-<i>exo</i>-(2-methylprop-1-enyl)- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C15H18ClNO
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=11.0631(7)Å b=5.7212(5)Å c=21.203(6)Å
α=90.00° β=102.587(16)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-8-chloro-9-methyl-2-<i>exo</i>-(prop-1-en-2-yl)- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C14H16ClNO
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=8.6828(11)Å b=10.1456(6)Å c=14.2976(16)Å
α=90.000° β=107.587(9)° γ=90.000°
2-exo-phenyl-2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C16H15NO
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=10.7475(7)Å b=10.7842(12)Å c=20.5812(19)Å
α=90.00° β=91.688(7)° γ=90.00°
(<i>2RS</i>,4<i>SR</i>)-2-(5-bromothiophen-2-yl)-2,3,4,5-tetrahydro-1,4-epoxynaphtho[1,2-<i>b</i>]azepine
C18H14BrNOS
Acta Crystallographica Section C (2013) 69, 3 307-312
a=15.316(2)Å b=9.9230(18)Å c=20.225(3)Å
α=90.000° β=90.000° γ=90.000°
Ethyl 3-amino-<i>N</i>-{2-amino-5-formyl-6-[methyl(phenyl)amino]pyrimidin- 4-yl}propionate
C17H21N5O3
Acta Crystallographica Section C (2013) 69, 2 162-171
a=16.707(6)Å b=10.218(2)Å c=20.733(5)Å
α=90.00° β=105.929(19)° γ=90.00°
<i>N</i>-{2-Amino-5-formyl-6-[methyl(phenyl)amino]pyrimidin-4-yl}glycinamide
C14H16N6O2
Acta Crystallographica Section C (2013) 69, 2 162-171
a=20.045(4)Å b=8.6868(7)Å c=17.990(3)Å
α=90.00° β=114.064(11)° γ=90.00°
Ethyl <i>N</i>-{2-amino-5-formyl-6-[methyl(phenyl)amino]pyrimidin-4-yl}glycinate
C16H19N5O3
Acta Crystallographica Section C (2013) 69, 2 162-171
a=7.3990(5)Å b=9.609(3)Å c=12.449(3)Å
α=73.30(2)° β=82.680(14)° γ=72.693(13)°
Methyl <i>N</i>-{2-amino-6-[benzyl(methyl)amino]-5-formylpyrimidin-4-yl}glycinate
C16H19N5O3
Acta Crystallographica Section C (2013) 69, 2 162-171
a=15.636(4)Å b=6.5674(18)Å c=17.336(5)Å
α=90.00° β=113.440(18)° γ=90.00°
Ethyl 3-amino-<i>N</i>-[2-amino-5-formyl-6-(piperidin-4-yl)pyrimidin-4-yl]propionate
C15H23N5O3
Acta Crystallographica Section C (2013) 69, 2 162-171
a=8.040(4)Å b=10.391(3)Å c=10.458(8)Å
α=109.16(3)° β=98.19(5)° γ=103.10(3)°
(2<i>R</i>,4<i>S</i>)-2-(3-Methylthiophen-2-yl)-2,3,4,5-tetrahydro-1,4-epoxynaphtho[1,2-<i>b</i>]-azepine
C19H17NOS
Acta Crystallographica Section C (2013) 69, 3 307-312
a=7.0387(3)Å b=11.5605(10)Å c=18.1951(17)Å
α=90.00° β=90.00° γ=90.00°
(2<i>RS</i>,4<i>SR</i>)-2-(5-Methylthiophen-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy-naphtho[1,2-<i>b</i>]azepine
C19H17NOS
Acta Crystallographica Section C (2013) 69, 3 307-312
a=16.165(2)Å b=5.2505(3)Å c=20.0410(19)Å
α=90.00° β=118.813(9)° γ=90.00°
(2<i>R</i>,4<i>S</i>)-7-Bromo-2-phenyl-2,3,4,5-tetrahydro-1,4- epoxynaphtho[1,2-<i>b</i>]azepine
C20H16BrNO
Acta Crystallographica Section C (2009) 65, 4 o140-o145
a=7.8444(3)Å b=9.8146(4)Å c=10.0871(4)Å
α=90.00° β=92.103(3)° γ=90.00°
4-Hydroxy-2-vinyl-2,3,4,5-tetrahydro-1-benzazepine
C12H15NO
Acta Crystallographica Section C (2009) 65, 3 o92-o96
a=10.3466(13)Å b=7.488(3)Å c=13.227(9)Å
α=90.00° β=92.94(2)° γ=90.00°
7-fluoro-4-hydroxy-2-vinyl-2,3,4,5-tetrahydro-1-benzazepine
C12H14FNO
Acta Crystallographica Section C (2009) 65, 3 o92-o96
a=10.5258(13)Å b=7.4501(13)Å c=13.251(2)Å
α=90.00° β=93.441(2)° γ=90.00°
(2RS,4SR)-7-bromo-2-(4-chlorophenyl-2,3,4,5-tetrahydro- 1,4-epoxynaphtho[1,2-<i>b</i>]azepine
C20H15BrClNO
Acta Crystallographica Section C (2009) 65, 4 o140-o145
a=9.7758(16)Å b=9.8211(14)Å c=33.174(3)Å
α=90.000° β=90.000° γ=90.000°
(2RS,4SR)-2-(4-fluorophenyl)-2,3,4,5-tetrahydro-1,4- epoxynaphtho[1,2-<i>b</i>]azepine
C20H16FNO
Acta Crystallographica Section C (2009) 65, 4 o140-o145
a=11.3036(4)Å b=12.7585(5)Å c=11.1730(3)Å
α=90.00° β=109.137(2)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-2-<i>exo</i>-(2-Chlorophenyl)-2,3,4,5-tetrahydro- 1<i>H</i>-1,4-epoxy-1-benzazepine
C16H14ClNO
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=8.8558(19)Å b=7.3585(13)Å c=9.9622(18)Å
α=90.00° β=101.622(17)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-2-<i>exo</i>-(2-Chloro-6-fluorophenyl)-2,3,4,5- tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C16H13ClFNO
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=9.0768(13)Å b=10.9461(9)Å c=12.9971(18)Å
α=90.00° β=99.768(9)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-7-methyl-2-<i>exo</i>-(4-methylphenyl)- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C18H19NO
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=9.7687(9)Å b=10.3022(17)Å c=14.239(2)Å
α=90.00° β=108.222(10)° γ=90.00°
C17H16ClNO
C17H16ClNO
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=8.7150(9)Å b=10.406(2)Å c=15.312(4)Å
α=99.547(19)° β=90.621(14)° γ=96.514(13)°
7-bromo-2-exo-phenyl-2,3,4,5-tetrahydro-1<i>H</i>-1,4- epoxy-1-benzazepine
C16H14BrNO
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=5.5214(3)Å b=10.2982(12)Å c=22.900(3)Å
α=90.00° β=90.00° γ=90.00°
(2<i>S</i>,4<i>R</i>)-7-fluoro-2-<i>exo</i>-[(<i>E</i>)-styryl]-2,3,4,5-\ tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C18H16FNO
Acta Crystallographica Section C (2010) 66, 4 o206-o208
a=10.052(4)Å b=5.299(4)Å c=12.976(8)Å
α=90.00° β=91.10(4)° γ=90.00°
2-exo-(4-chlorophenyl)-2,3,4,5-tetrahydro-1<i>H</i>- 1,4-epoxy-1-benzazepine
C16H14ClNO
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=8.2405(14)Å b=11.5432(16)Å c=27.442(2)Å
α=90.00° β=101.030(13)° γ=90.00°
2-exo-(3-methylphenyl)-2,3,4,5-tetrahydro-1<i>H</i>-1,4- epoxy-1-benzazepine
C17H17NO
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=10.9966(17)Å b=23.691(10)Å c=10.6323(8)Å
α=90.00° β=111.661(8)° γ=90.00°
2-exo-(4-bromophenyl)-7-chloro-2,3,4,5- tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C16H13BrClNO
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=15.3626(16)Å b=11.5436(13)Å c=7.8832(13)Å
α=90.00° β=96.080(11)° γ=90.00°
(2<i>RS</i>,4<i>RS</i>)-8-chloro-9-methyl-2-<i>endo</i>-(2-methylprop-1-enyl)- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C15H18ClNO
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=5.2890(9)Å b=9.3076(16)Å c=13.551(3)Å
α=94.554(15)° β=94.684(15)° γ=97.298(14)°
(2<i>SR</i>,4<i>RS</i>)-7-chloro-2-<i>exo</i>-(2-methylprop-1-enyl)- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C14H16ClNO
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=5.6445(5)Å b=25.744(3)Å c=8.3894(11)Å
α=90.00° β=95.124(9)° γ=90.00°
5-Acetyl-2-chloro-8,11-dimethyl-5,6,11,12- tetrahydrodibenzo[<i>b</i>,<i>f</i>]azocine
C19H20ClNO
Acta Crystallographica Section C (2010) 66, 6 o284-o288
a=8.3396(3)Å b=21.7131(7)Å c=9.2010(3)Å
α=90.00° β=106.683(2)° γ=90.00°
14-acetyl-8,11-dimethyl-7,8,13,14- tetrahydrobenzo[<i>f</i>]naphtho[1,2-<i>b</i>]azocine--14-acetyl- 8,9-dimethyl-7,8,13,14-tetrahydrobenzo[<i>f</i>]naphtho[1,2-<i>b</i>]azocine (74/26)
C23H23NO
Acta Crystallographica Section C (2010) 66, 6 o284-o288
a=18.9549(10)Å b=9.8917(4)Å c=9.4354(5)Å
α=90.00° β=97.348(3)° γ=90.00°
(2SR,4RS)-7-Chloro-2-<i>exo</i>-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
C18H16ClNO
Acta Crystallographica Section C (2008) 64, 9 o514-o518
a=10.5798(8)Å b=5.3448(10)Å c=12.873(3)Å
α=90.00° β=90.204(12)° γ=90.00°
(2RS,4RS)-7-Chloro-2-<i>endo</i>-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
C18H16ClNO
Acta Crystallographica Section C (2008) 64, 9 o514-o518
a=5.2855(10)Å b=15.649(2)Å c=17.880(3)Å
α=90.00° β=90.00° γ=90.00°
(2<i>R</i>,4<i>R</i>)-7-fluoro-2-endo-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
C18H16FNO
Acta Crystallographica Section C (2008) 64, 9 o514-o518
a=5.4172(2)Å b=8.0164(6)Å c=16.2310(11)Å
α=90.00° β=96.745(4)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-2-<i>exo</i>-(5-bromo-2-thienyl)-7-trifluoromethoxy- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C15H11BrF3NO2S
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=5.6913(6)Å b=10.1187(6)Å c=13.2996(13)Å
α=90.00° β=100.497(8)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-7-chloro-2-<i>exo</i>-(2-chlorophenyl)- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C16H13Cl2NO
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=7.4328(11)Å b=12.3746(16)Å c=14.9187(19)Å
α=90.00° β=90.00° γ=90.00°
(2<i>S</i>,4<i>R</i>)-7-chloro-2-<i>exo</i>- (1-naphthyl)-2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C20H16ClNO
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=9.6174(18)Å b=11.558(3)Å c=13.465(4)Å
α=90.00° β=90.00° γ=90.00°
(2SR,4RS)-2-<i>exo</i>-(5-bromo-2-thienyl)-7-fluoro- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C14H11BrFNOS
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=8.1835(6)Å b=10.9447(8)Å c=14.6940(12)Å
α=90.00° β=104.969(6)° γ=90.00°
(2SR,4RS)-7-Fluoro-2-<i>exo</i>-(2-furyl)-2,3,4,5-tetrahydro-1H-1,4-epoxy- 1-benzazepine
C14H12FNO2
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=5.5314(10)Å b=15.430(4)Å c=26.229(6)Å
α=90.00° β=92.960(17)° γ=90.00°
(2SR,4RS)-7-chloro-2-<i>exo</i>-(4-chlorophenyl)-2,3,4,5-tetrahydro- 1H-1,4-epoxy-1-benzazepine
C16H13Cl2NO
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=11.9348(11)Å b=21.617(2)Å c=5.3024(6)Å
α=90.00° β=90.00° γ=90.00°
(2<i>S</i>*,4<i>R</i>*)-2-<i>exo</i>-(1-Naphthyl)-7-trifluoromethyl-2,3,4,5- tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C21H16F3NO2
Acta Crystallographica Section C (2010) 66, 11 o540-o546
a=7.2209(5)Å b=13.140(2)Å c=17.559(2)Å
α=90.00° β=90.00° γ=90.00°